Isosorbide Dinitrate
Brand names,
Isosorbide Dinitrate
Analogs
Isosorbide Dinitrate
Brand Names Mixture
Isosorbide Dinitrate
Chemical_Formula
C6H8N2O8
Isosorbide Dinitrate
RX_link
http://www.rxlist.com/cgi/generic2/isodinit.htm
Isosorbide Dinitrate
fda sheet
Isosorbide Dinitrate
msds (material safety sheet)
Isosorbide Dinitrate
Synthesis Reference
Goldberg, Acta physiol. Scand.15, 173(1948)
Isosorbide Dinitrate
Molecular Weight
236.136 g/mol
Isosorbide Dinitrate
Melting Point
70 oC
Isosorbide Dinitrate
H2O Solubility
1.089 mg/mL
Isosorbide Dinitrate
State
Solid
Isosorbide Dinitrate
LogP
-0.53
Isosorbide Dinitrate
Dosage Forms
Oral tablet
Isosorbide Dinitrate
Indication
For the prevention of angina pectoris due to coronary artery disease.
Isosorbide Dinitrate
Pharmacology
Isosorbide Dinitrate is a moderate to long acting oral organic nitrate used for the relief and prophylactic management of angina pectoris. It relaxes the vascular smooth muscle and consequent dilatation of peripheral arteries and veins, especially the latter. Dilatation of the veins promotes peripheral pooling of blood and decreases venous return to the heart, thereby reducing left ventricular end- diastolic pressure and pulmonary capillary wedge pressure (preload). Arteriolar relaxation reduces systemic vascular resistance, systolic arterial pressure, and mean arterial pressure.
Isosorbide Dinitrate
Absorption
Absorption of isosorbide dinitrate after oral dosing is nearly complete, but bioavailability is highly variable (10% to 90%), with extensive first-pass metabolism in the liver. The average bioavailability of isosorbide dinitrate is about 25%.
Isosorbide Dinitrate
side effects and Toxicity
Symptoms of overdose include reduced cardiac output and hypotension.
Isosorbide Dinitrate
Patient Information
PATIENT INFORMATION
Patients should be told that the anti-anginal efficacy of isosorbide dinitrate is strongly related
to its dosing regimen, so the prescribed schedule of dosing should be followed carefully. In
particular, daily headaches sometimes accompany treatment with isosorbide dinitrate. In patients
who get these headaches, the headaches are a marker of the activity of the drug. Patients should
resist the temptation to avoid headaches by altering the schedule of their treatment with isosorbide
dinitrate, since loss of headache may be associated with simultaneous loss of anti-anginal efficacy.
Aspirin and/or acetaminophen, on the other hand, often successfully relieve isosorbide dinitrate-
induced headaches with no deleterious effect an isosorbide dinitrate's anti-anginal efficacy.
Treatment with isosorbide dinitrate may be associated with lightheadedness on standing, especially
just after rising from a recumbent or seated position. This effect may be more frequent in patients
who have also consumed alcohol
Isosorbide Dinitrate
Organisms Affected
Humans and other mammals